Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The research developed new fortilin protein constructs for potential heart disease treatments.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Finasteride may improve prostate cancer treatment outcomes.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Epristeride's metabolism in zebrafish helps improve doping detection methods.